A new study provided a deeper insight into the development of Alzheimer's disease.
Dr Rick Livesey and his team at the Gurdon Institute in Cambridge are working with Alzheimer's Research UK, using state-of-the-art stem cell technology to develop a better understanding of how the disease starts and then progresses, the Daily Express reported.
Dr Livesey makes a "mini brain" that scientists can use to observe the disease for its entire cycle.
Dr Livesey approached the charity to see if there was a way to replicate sporadic Alzheimer's disease in the lab and he has been given a grant of 2million pounds over five years from the Alborada Trust to see if this is possible, and to use their findings in the development of new drugs.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app